Application

AMNIPLY

Xiaosong Yang

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88877985
Filing Date: 04/19/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88877985
MARK INFORMATION
*MARK Amniply
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT Amniply
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Xiaosong Yang
INTERNAL ADDRESS 6114 BULLARD DR
*MAILING ADDRESS 6114 BULLARD DR, A
*CITY Austin
*STATE
(Required for U.S. applicants)
Texas
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
78757
PHONE 512-656-0858
*EMAIL ADDRESS thomas@log-alert.com
WEBSITE ADDRESS www.internationaltissue.com
LEGAL ENTITY INFORMATION
TYPE individual
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF CITIZENSHIP United States
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Biological amniotic membrane tissue intended for subsequent implantation
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 03/01/2020
       FIRST USE IN COMMERCE DATE At least as early as 03/01/2020
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT18\IMAGEOUT 18\888\779\88877985\xml1\ APP0003.JPG
       SPECIMEN DESCRIPTION Commercial packaging box for the Amniply product.
CORRESPONDENCE INFORMATION
NAME Xiaosong Yang
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE thomas@log-alert.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) xyang@internationaltissue.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 275
*TOTAL FEES PAID 275
SIGNATURE INFORMATION
SIGNATURE /Xiaosong Yang/
SIGNATORY'S NAME Xiaosong Yang
SIGNATORY'S POSITION Owner
SIGNATORY'S PHONE NUMBER 512-656-0858
DATE SIGNED 04/19/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88877985
Filing Date: 04/19/020

To the Commissioner for Trademarks:

MARK: Amniply (Standard Characters, see mark)
The literal element of the mark consists of Amniply. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Xiaosong Yang, a citizen of United States, having an address of
      6114 BULLARD DR
      6114 BULLARD DR, A
      Austin, Texas 78757
      United States
      512-656-0858(phone)
      thomas@log-alert.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Biological amniotic membrane tissue intended for subsequent implantation

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 03/01/2020, and first used in commerce at least as early as 03/01/2020, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) Commercial packaging box for the Amniply product..
Specimen File1



For informational purposes only, applicant's website address is: www.internationaltissue.com
The applicant's current Correspondence Information:
      Xiaosong Yang
       PRIMARY EMAIL FOR CORRESPONDENCE: thomas@log-alert.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): xyang@internationaltissue.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Xiaosong Yang/   Date: 04/19/2020
Signatory's Name: Xiaosong Yang
Signatory's Position: Owner
Payment Sale Number: 88877985
Payment Accounting Date: 04/20/2020

Serial Number: 88877985
Internet Transmission Date: Sun Apr 19 13:12:12 ET 2020
TEAS Stamp: USPTO/BAS-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20200419131212996515-88877985-
7104d2652656dd8e45bdfed817274aea4fd67196
79fad6d5784ba698798f8e6020-CC-12112015-2
0200419124940096213

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed